ACEA Therapeutics (aceatherapeutics.com) is a clinical-stage biopharmaceutical company developing innovative small-molecule and antibody-drug-conjugate treatments across oncology, autoimmune, and antiviral therapeutic areas, with product candidates including Olgotrelvir, Abivertinib, AC0058, STI-6129, and AC0939. - View it on GitHub